Lyra Health vs Calm
Side-by-side comparison of model-estimated upside.
Lyra Health
-32%
est. 2Y upside i
Rank
#2888
Sector
HealthTech
Est. Liquidity
~2Y
Data Quality
Data: MediumGiven the negative expected upside (-32.4%) over 2 years, this equity grant is likely to lose value.
Last updated: July 3, 2026
Calm
+126%
est. 2Y upside i
Rank
#165
Sector
Health Care Technology
Est. Liquidity
~3Y
Data Quality
Data: MediumBased on the analysis, the expected equity upside over 2 years is 126%, with moderate risk.
Last updated: July 21, 2026
Note: These companies have different risk levels. Lyra Health (Higher Risk) and Calm (Moderate Risk). A higher expected upside in a higher-risk company comes with greater uncertainty. Compare within the same risk tier for more meaningful evaluation.
Upside Comparison
Expected Upside
Disclaimer: These rankings are AI-generated estimates and do not constitute financial or career advice. Always conduct your own due diligence.